Autolus directors Anderson and Murphy will not stand for re-election at 2025 AGM

Autolus Therapeutics plc

Joseph Anderson and Martin Murphy notified the board on May 23, 2025, of their decision.
Both directors stated the decision was not due to any disagreement with management or the board.
Their departure takes effect at the 2025 Annual General Meeting of Shareholders.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Martin Murphy

Director

AUTL · Autolus Therapeutics plc

Filed: May 30, 2025 23:59 UTC

On May 23, 2025, Drs. Joseph Anderson and Martin Murphy, members of the Board of Directors (the “Board”) of Autolus Therapeutics plc (the “Company”), notified the Company of their intention not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders.

Departed

Joseph Anderson

Director

AUTL · Autolus Therapeutics plc

Filed: May 30, 2025 23:59 UTC

On May 23, 2025, Drs. Joseph Anderson and Martin Murphy, members of the Board of Directors (the “Board”) of Autolus Therapeutics plc (the “Company”), notified the Company of their intention not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders.

Source: SEC EDGAR

accession 0001193125-25-132111

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.